GenMark Diagnostics Submits Test for Coronavirus to FDA

4y ago, source: TheStreet.com

GenMark Diagnostics submitted a test for coronavirus to the Food and Drug Administration. The company seeks quick clearance of the test through an FDA emergency-use authorization. Shares of ...

Roche expands COVID testing portfolio with $1.8bn GenMark deal

3y ago, source: pharmaphorum

Meanwhile, GenMark said that the deal will help expand the reach of its products. “Together with Roche’s diagnostics healthcare solutions, we will be able to provide a full suite of molecular ...

Quest Diagnostics Inc DGX

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Lucid Diagnostics Inc. (LUCD)

3d ago, source: Yahoo Finance

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq ...

Accelerate Diagnostics Inc AXDX

6d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Bluejay Diagnostics, Inc.

2y ago, source: CNN

Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access ...

PAVmed Inc. (PAVM)

2d ago, source: Yahoo Finance

PAVmed Inc. (PAVM) closed at $2.07 in the latest trading session, marking a -1.43% move from the prior day. Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage ...

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q4 2023 Earnings Call Transcript

26d ago, source: Hosted on MSN

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q4 2023 Earnings Call Transcript March 28, 2024 Accelerate Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.89 EPS, expectations ...

Accelerate Diagnostics Inc.

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Quest Diagnostics Inc.

10d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

AXDX Accelerate Diagnostics, Inc.

2d ago, source: Seeking Alpha

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers ...

Quest Diagnostics Inc.

3y ago, source: Wall Street Journal

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...